UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Legacy Wealth Management LLC MS

Legacy Wealth Management LLC MS lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,424 shares of the healthcare conglomerate’s stock after acquiring an additional 180 shares during the quarter. UnitedHealth Group accounts for 1.4% of Legacy Wealth Management LLC MS’s holdings, making the stock its 17th biggest position. Legacy Wealth Management LLC MS’s holdings in UnitedHealth Group were worth $4,412,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group in the fourth quarter valued at $26,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. Finally, Promus Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter worth approximately $32,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other UnitedHealth Group news, CEO Stephen J. Hemsley bought 86,700 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The shares were bought at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the acquisition, the chief executive officer now directly owns 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director John H. Noseworthy purchased 300 shares of the company’s stock in a transaction on Wednesday, May 14th. The stock was acquired at an average price of $312.16 per share, with a total value of $93,648.00. Following the purchase, the director now owns 6,063 shares of the company’s stock, valued at approximately $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Barclays decreased their target price on UnitedHealth Group from $513.00 to $362.00 and set an “overweight” rating on the stock in a research report on Thursday, May 15th. Royal Bank of Canada dropped their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating on the stock in a research report on Friday, May 16th. Hsbc Global Res lowered shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, May 21st. Mizuho reduced their target price on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a report on Friday, May 16th. Finally, TD Securities reiterated a “hold” rating and set a $308.00 price target (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $441.87.

UnitedHealth Group Trading Up 0.8%

Shares of UnitedHealth Group stock opened at $297.49 on Thursday. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market capitalization of $269.87 billion, a price-to-earnings ratio of 19.19, a PEG ratio of 1.37 and a beta of 0.56. The stock has a 50 day moving average of $439.50 and a 200 day moving average of $498.65.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. During the same period last year, the business earned $6.91 EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.